Mammakarzinom beim Mann

Zusammenfassung

Männlicher Brustkrebs ist für viele Ärzte ein unbekanntes Gebiet. Die Patienten gehen oft zu verschiedenen Ärzten, bevor die richtige Diagnose gestellt wird – meist zu spät. Dieser Artikel soll Risikofaktoren sowie die Einleitung von Diagnostik und Therapie aufzeigen. Im anbrechenden Zeitalter der molekularen Medizin werden wir auch einen Blick auf die Genetik werfen.

Abstract

Male breast cancer is an unknown field for many practitioners. Patients often see different doctors before the correct diagnosis is made – often too late. This article is intended to point out risk factors, initiation of diagnostics and therapy. In the dawning age of molecular medicine, we will also take a look at genetics.

Schlüsselwörter

Brustkrebs - Männer - Diagnostik

Keywords

breast cancer - men - diagnostics

• Literatur

• 1 Zentrum für Krebsregisterdaten (RKI), Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland für 2015/2016. 12. Ausg. korrigierte Fassung vom 17.08.2020. Robert Koch-Institut: Berlin. 2019
• 2 Wang F, Shu X, Meszoely I. et al. Overall Mortality After Diagnosis of Breast Cancer in Men vs. Women. JAMA Oncol 2019; 5: 1589-1596
• 3 Thomas DB, Jimenez M, McTieman A. et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734-748
• 4 Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelterʼs syndrome. J Med Genet 1971; 8: 460
• 5 Hultborn R, Hanson C, Köpf I. et al. Prevalence of Klinefelterʼs syndrome in male breast cancer patients. Anticancer Res 1997; 17: 4293-4297
• 6 Brinton LA, Cook MB, McCormack V. et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst 2014; 106: djt465
• 7 Ferzoco RM, Ruddy KJ. The Epidemiology of Male Breast Cancer. Curr Oncol Rep 2015; 18: 1
• 8 Brinton LA, Key TJ, Kolonel LN. et al. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol 2015; 33: 2041-2050
• 9 Johansen Taber KA, Morisy LR, Osbahr 3rd AJ. et al. Male breast cancer: risk factors, diagnosis, and management (Review). Oncol Rep 2010; 24: 1115-1120
• 10 Hsing AW, McLaughlin JK, Cocco P. et al. Risk factors for male breast cancer (United States). Cancer Causes Control 1998; 9: 269-275
• 11 Cook MB, Guénel P, Gapstur SM. et al. Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev 2015; 24: 520-531
• 12 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, AWMF). Konsultationsfassung der S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms 2020. Version 4.04. AWMF-Registernummer: 032–045OL.
• 13 Tai YC, Domchek S, Parmigiani G. et al. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99: 1811-1814
• 14 Risch HA, McLaughlin JR, Cole DEC. et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006; 98: 1694-1706
• 15 Mersch J, Jackson MA, Park M. et al. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 2015; 121: 269-275
• 16 Oh M, McBride A, Yun S. et al. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Metaanalysis. J Natl Cancer Inst 2018; 110: 1178-1189
• 17 Evans DG, Susnerwala I, Dawson J. et al. Risk of breast cancer in male BRCA2 carriers. J Med Genet 2010; 47: 710-711
• 18 van Asperen CJ, Brohet RM, Meijers-Heijboer EJ. et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005; 42: 711-719
• 19 Doyle S, Steel J, Porter G. Imaging male breast cancer. Clin Radiol 2011; 66: 1079-1085
• 20 Gao Y, Heller SL, Moy L. Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance. Radiographics 2018; 38: 1289-1311
• 21 Leon-Ferre RA, Giridhar KV, Hieken TJ. et al. A contemporary review ofmale breast cancer: current evidence and unanswered questions. Cancer Metastasis Rev 2018; 37: 599-614